Cassie Gorsuch, PhD
Vice President, Gene Therapy
Cassie Gorsuch, PhD is Vice President, Gene Therapy and Heads the Gene Therapy Discovery team, which is responsible for preclinical evaluation of ARCUS nucleases for in vivo gene editing programs. Dr. Gorsuch is a subject matter expert in gene therapy at Precision and also serves on the steering committees for many of our partnerships. Prior to Precision, Dr. Gorsuch was a life science specialist with VWR, a global supplier of laboratory research products. Dr. Gorsuch received her PhD in Biological Sciences (cell/molecular biology focus) from the University of Notre Dame and Bachelor of Science in Biochemistry from Rockhurst University.